i&i Prague

07/02/2023

👋 Let us introduce a new member of our portfolio:

Sophomer Ltd. is an academic startup founded by a group of people who come from both industry and academia. Their vision is to bring together two seemingly unrelated fields: immunoassays and polymer chemistry to help anyone who uses immunochemical assays in their work. One of the startup's first products is SophoMer(TM), a polymer that can replace the widely used bovine serum albumin in immunochemical assays.

Sophomer today announced the signing of a licensing agreement to commercialize this technology, which has been developed in collaboration between the Institute of Macromolecular Chemistry, Czech Academy of Sciences, Elisa Development and our bio-innovation center.

We would also like to thank Centrum transferu technologií AV ČR who helped with the licensing of this agreement.

Read more in the press release. 👇

BSA is one of the oldest industrially derived proteins. In immunoassays it is primarily used as a blocker, which makes the measurements more accurate by suppressing unwanted signals. It is derived from bovine serum, which poses a number of problems. These include the risk of pathogen transmission, w...

24/01/2023

🎧 CEO našeho fondu Jaromír Zahrádka byl hostem pořadu Experiment, který vysílá Český rozhlas Radiožurnál.

Z pozice potencionálního investora hodnotil projekt vědců ze Západočeské univerzity v Plzni, kterým se podařilo vyrobit čerpadlo, které je tak malé, že se vejde i do mikročipů.

Více v přiloženém audiu, pasáž obsahující rozhovor s Jaromírem Zahrádkou začíná v čase 4:20. 👇

00:00 témata magazínu;00:36 magnetické mikročerpadlo vědců z Plzně;04:19 možnosti využití mikročerpadla;08:27 filtry na vodu z nedopalků;11:49 detaily Svatováclavské koruny;14:48 středisko molekulární biologie EMBL

12/01/2023

The renowned Czech economist will join the European Investment Fund's (EIF) delegate as a representative of our bio-innovation center and the innovation ecosystem around IOCB Prague, to support the further development of i&i Biotech Fund.

i&i Biotech Fund (i&i Bio) is the venture capital firm that invests in innovative European Life Sciences companies focused on Drug Discovery, Diagnostics, MedTech and other Life Science fields. We established i&i Bio in cooperation with the EIF.

For more information, visit the webpage of i&i Bio 👉 www.inibio.eu/news

23/02/2021

🧬i&i Prague is a member of Transfera.cz, an association connecting technology-transfer offices of the best Czech research institutes, universities as well as patent attorneys etc.

In December 2020 Transfera.cz prepared so called Transfera Technology Day, a conference connecting investors with the best projects of Transfera database, choosing one with the biggest market potential. Be sure to read more about winners and finalists down bellow as well as to follow Transfera.cz 👍

16/02/2021

We are delighted that after months of negotiations, Enantis, one of i&i Prague´s first supported start-ups, has entered into a global license agreement with one of the top providers of life science solutions with their innovative FGF2-STAB® molecule and its use in research and cell therapy market.

Read more about this Masaryk University spin-off on the official MUNI webpage or in the article down bellow!

https://www.iniprague.com/enantis-masaryk-university-spin-off-company-concluded-license-agreement-for-the-production-of-stabilised-growth-factor-fgf2/

After months of negotiations, we are delighted to announce that Enantis, one of i&i Prague´s first supported start-ups, has entered into a global license agreement with one of the top providers of life science solutions with ther innovative FGF2-STAB® molecule and its use in research and cell ther...

07/01/2021

🧬Don´t miss this interesting report on ČT24 about the newest Masaryk University spin-off: CasInvent Pharma, a.s.!

https://www.ceskatelevize.cz/ivysilani/10101491767-studio-ct24/221411058330105

🧪CasInvent in an university spin-off supported by i&i Prague,
which develops inhibitors used to treat certain types of , and solid

🧪We are very glad to see that this important and interesting news is spread and shared by Czech major media.

Thank you, Česká televize !

Aktuální situace v nemocnicích Vývoj pandemie ve Španělsku Vývoj slibných látek pro léčbu leukémie

23/12/2020

🧬i&i Prague team wishes you peaceful and merry holidays and a successful new year 2021!

We believe next year will bring many new opportunities and will be ready to support the best scientists and innovations once again👍

In our 3 years of existence we helped establish 9 new start-ups, helped them raise money and shared our know-how and network of international contacts. We wish all theSe new spin-off companies as well as you good luck in the next year 2021 and are looking forward to many more collaborations, too!